Skip to main navigation MENU Investors Investors INVESTORS IR Nav Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market. We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins. Recent News TELIGENT TO PURSUE ASSET SALE THROUGH VOLUNTARY CHAPTER 11 PROCESS Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash c... LEARN MORE TELIGENT, INC. ANNOUNCES SECOND QUARTER 2021 EARNINGS REPORT AND PROVIDES BUSINESS UPDATE – Update on FDA Inspection of Buena Facility – Assessing New Growth Opportunities in Injectables – Conference Call to Be... LEARN MORE TELIGENT, INC. TO HOLD CONFERENCE CALL FOR SECOND QUARTER 2021 FINANCIAL RESULTS ON MONDAY, AUGUST 16, 2021 BUENA, N.J. , Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jer... LEARN MORE SEE ALL NEWS Events August 16, 2021 at 8:30 AM EDT Teligent, Inc. Second Quarter 2021 Results MORE Investor Overview There are no items to display. Stock Information NASDAQ: TLGT -- Change0.0 (0.00%) Volume0 52 Week High$1.60 52 Week Low$0.17 Nov 24, 2021 4:12 PM EST Data Provided by Refinitiv. Minimum 15 minutes delayed. FULL QUOTE WHO WE ARE OUR SCIENCE PIPELINE & PRODUCTS INVESTORS CAREERS CONTACT US CONNECT ON IR Tools EMAIL ALERTS RSS PRINT SEARCH © Copyright 2021 Teligent. All Rights Reserved. Footer Bottom Nav Site Map Privacy Policy Terms & Conditions